Banking Placenta-Derived Stem Cells Can Lead to Great Potential Health Benefits

admin @ February 18, 2009 # No Comment Yet

Umbilical cord blood, bone marrow, and circulating blood were once the three primary sources of CD34+ stem cells, but research has revealed an abundant fourth source: the placenta. Banking placenta-derived stem cells can lead to significant potential health benefits.
Since the placenta is up to 15 times richer in CD34+ stem cells than cord blood, banking […]

More on page 165

Capitalize on the Opportunity to Bank Newborn Cord Blood with LifebankUSA™

admin @ February 7, 2009 # No Comment Yet

Newborn cord blood is rich in CD34+ stem cells that have proven capable of treating approximately 80 potentially life-threatening diseases and conditions to date, including some cancers, certain lymphomas, and various immune system disorders. Expecting parents have a once-in-a-lifetime opportunity to have their newborn’s cord blood banked to secure increased future treatment options for their […]

More on page 164